What Is a PSC Cataract and How Is It Treated?

A posterior subcapsular cataract (PSC) is a cloudy patch that forms on the back surface of the lens, right in front of the thin membrane called the posterior capsule. Unlike the more common nuclear cataracts that slowly yellow the center of the lens with age, a PSC sits directly in the path of light heading toward the retina, which is why even a small one can cause surprisingly disproportionate vision trouble. PSC cataracts are strongly linked to steroid use, diabetes, and radiation exposure, and they tend to affect people at younger ages than other cataract types.

Why PSC Cataracts Cause So Much Trouble for Their Size

The location of a PSC makes it uniquely disruptive. Because the opacity sits at the back of the lens, close to the eye’s focal point, it scatters incoming light right before it converges on the retina. This means a relatively thin, small plaque of clouded lens tissue can slash visual quality far more than a much denser nuclear cataract would. The effect is especially pronounced in bright light or when you are trying to read. When your pupil constricts in sunlight or while focusing on something close, more of the light funnels through that central posterior zone where the PSC lives.

Glare is the hallmark complaint. Research has shown that both daytime and nighttime glare sensitivity are closely tied to the severity of posterior subcapsular cataracts, more so than with nuclear or cortical types.1PubMed. Contrast and glare sensitivity. Association with the type and severity of the cataract This glare can make driving at night genuinely dangerous, with oncoming headlights blooming into large halos that wash out the road. Reading menus in a dimly lit restaurant, working on a backlit computer screen, or stepping outside on a sunny day can all become frustrating in ways that standard visual acuity tests might not fully capture.

That gap between what a standard eye chart reveals and what patients actually experience is a recurring theme with PSC cataracts. Studies have found that contrast sensitivity at lower spatial frequencies drops in PSC patients independently of their measured visual acuity.2PubMed. Contrast sensitivity and glare sensitivity changes with three types of cataract morphology: are these techniques necessary in a clinical evaluation of cataract? In practical terms, you might still read the 20/30 line on a high-contrast letter chart at the eye doctor’s office but struggle badly with low-contrast tasks in the real world, like spotting a gray car against a gray sky or reading faded print. This discrepancy sometimes leads patients to feel dismissed when they report significant visual difficulty despite “decent” acuity numbers.

What Causes a PSC Cataract

Aging alone can produce a PSC, but it is far less common as a purely age-related change than nuclear sclerosis. PSC cataracts have a roster of well-established risk factors that distinguishes them from other cataract types, and many of those risk factors skew younger.

Corticosteroid Use

Prolonged use of glucocorticoids is the single most recognized modifiable risk factor.3PubMed. What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts The connection applies to oral steroids, inhaled steroids for asthma, steroid eye drops, and even injected steroids for joint or skin conditions. Epidemiological data suggest that more than a third of patients who take systemic corticosteroids for longer than about two months develop cataracts, with PSC being the characteristic type.4PubMed Central. Cataract Induced by Glucocorticoids The risk climbs with higher doses and longer duration. There is some debate over whether steroid-induced PSC can reverse if the medication is stopped early enough; anecdotal reports exist, but once the opacity is well established, the changes are permanent.

Diabetes

Diabetes promotes cataracts through several biochemical pathways, but the connection to PSC specifically involves the buildup of sorbitol inside the lens. In people with high blood glucose, an enzyme converts excess glucose into sorbitol faster than it can be cleared. That sorbitol draws water into lens fibers, eventually causing them to swell and degenerate. Research has found that the activity level of this enzyme in younger diabetic patients correlates positively with the prevalence of posterior subcapsular cataracts.5PubMed Central. Cataract in diabetes mellitus This helps explain why some diabetic patients develop PSC cataracts decades earlier than the general population would be expected to.

Radiation Exposure

Both ionizing and ultraviolet radiation can trigger PSC formation. A 20-year study of radiologic technologists found that the link between occupational radiation dose to the eye and cataract risk was strongest among those diagnosed before age 50, when PSC is the dominant type of lens opacity from radiation.6PubMed Central. Risk of Cataract after Exposure to Low Doses of Ionizing Radiation: A 20-Year Prospective Cohort Study among US Radiologic Technologists Intense ultraviolet exposure has also been reported as a risk factor in case reports, with a patient who had no other known risk factors developing bilateral PSC after severe UV exposure.7Eye. Posterior subcapsular cataract following intense ultraviolet radiation exposure: A case report This is relevant for people who work outdoors without UV-blocking eyewear, as well as those exposed to medical or industrial radiation sources.

Ocular Inflammation and Retinal Disease

Chronic inflammation inside the eye, such as uveitis, is a well-known trigger. In one documented case, severe uveitis caused by a cancer immunotherapy drug led to posterior subcapsular cataracts, illustrating how intense intraocular inflammation can drive PSC formation even as a secondary consequence of another treatment.8Canadian Journal of Ophthalmology. Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report Retinitis pigmentosa, a group of inherited retinal degenerations, is also associated with PSC at high rates. In a study of nearly 300 patients with various hereditary retinal diseases, the overall frequency of PSC was about 41%, with the highest rates in those with autosomal dominant retinitis pigmentosa.9American Journal of Ophthalmology. The Frequency of Posterior Subcapsular Cataract in the Hereditary Retinal Degenerations This means that if you carry a diagnosis of retinitis pigmentosa, a PSC cataract is something to watch for proactively.

How the Opacity Actually Forms

The lens has a single layer of epithelial cells across its front surface. Normally, these cells divide near the equator of the lens and differentiate into the long, transparent fibers that make up the bulk of the lens. In PSC cataracts, something goes wrong with that orderly process. Studies using microscopy have shown that epithelial cells migrate toward the posterior pole of the lens, where they do not belong. In these zones, the normal rows of cell nuclei become completely disorganized, and the migrating cells take on an abnormal stellate shape, layering over one another and eventually forming a ring pattern around a liquefied central area.10JAMA Ophthalmology. Human Posterior Subcapsular Cataract: A Gross and Flat Preparation Study

These misplaced cells are the opacity you see on examination. They scatter light and, as the cataract progresses, they produce bladder cells (swollen, degenerating fiber cells) that further cloud the area. The growth factor TGF-beta plays a key role in driving this abnormal cell behavior. When TGF-beta signaling ramps up inappropriately in lens epithelial cells, it triggers a process where epithelial cells lose their normal characteristics and begin acting more like wound-healing cells, laying down scar-like proteins including collagen and fibronectin while losing the transparent crystallin proteins the lens depends on for clarity.11Cells Tissues Organs. Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition in the Lens: A Model for Cataract Formation This same mechanism is implicated in secondary cataracts that form after cataract surgery, which is one reason PSC patients sometimes face a related complication down the road.

A review of PSC risk factors has proposed a two-stage model: an initial insult (steroid exposure, radiation, inflammation, or metabolic stress) damages the lens environment, followed by a latent period during which chronic inflammation and premature aging mechanisms drive the opacity toward a mature plaque.12PubMed. Etiology of posterior subcapsular cataracts based on a review of risk factors including aging, diabetes, and ionizing radiation This latent period explains why someone exposed to radiation or a steroid course might not develop a noticeable PSC until months or even years later.

How PSC Cataracts Are Detected and Graded

An eye doctor typically spots a PSC during a dilated slit-lamp examination. With the pupil wide open, the examiner can use retroillumination, shining light through the pupil and looking at the shadow the opacity casts against the red reflex from the retina. A PSC shows up as a dark, granular, or plaque-like shadow in the central posterior region of the lens. This is quite different from the hazy glow of a nuclear cataract or the spoke-like opacities of a cortical cataract.

For research and standardization, ophthalmologists use the Lens Opacities Classification System III (LOCS III), which provides reference photographs for grading. Posterior subcapsular cataracts are graded using five retroillumination images on a scale of severity.13PubMed. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group Recently, deep-learning algorithms have been trained to grade PSC severity from these same retroillumination images, achieving accuracy above 87% for LOCS III-based grading and diagnostic accuracy above 92% for detecting PSC.14Ophthalmology Science. Deep Learning-Based Cataract Detection and Grading from Slit-Lamp and Retro-Illumination Photographs: Model Development and Validation Study These tools are being developed for screening in areas where specialist access is limited, though they are not yet standard in everyday clinical practice.

One additional tool gaining attention for PSC specifically is optical coherence tomography (OCT) of the lens. Because PSC cataracts can adhere to or thin the posterior capsule in ways that create surgical complications, preoperative OCT imaging can help surgeons assess how tightly the opacity is attached to the capsule before they operate.15PubMed. Preoperative OCT lens evaluation in posterior subcapsular cataract – prevention of complications from phacoemulsification

Surgery and Its Particular Challenges With PSC

Cataract surgery, specifically phacoemulsification, remains the standard and most effective treatment. In this procedure, an ultrasound-tipped probe breaks up and aspirates the clouded lens through a tiny incision, and an artificial intraocular lens is placed inside the remaining capsular bag. After uncomplicated surgery, patients with PSC cataracts routinely achieve excellent vision. One case report documents a patient reaching 20/20 acuity after phacoemulsification for PSC, and this kind of outcome is typical when everything goes well.

The catch is that PSC cataracts pose some unique technical challenges during surgery. Because the opacity sits right on the posterior capsule, the surgeon must work carefully in a zone where the capsule is thin and potentially weakened. If the posterior capsule ruptures during surgery, the vitreous gel behind it can spill forward, turning a routine operation into a more complex one. A study of posterior capsule rupture cases during phacoemulsification found that PSC cataracts were the second most common cataract type involved, accounting for about a quarter of the eyes with this complication.16Arquivos Brasileiros de Oftalmologia. Clinical features, management, and outcomes of posterior capsule rupture during phacoemulsification surgery The risk is higher when the PSC plaque is dense and firmly adherent to the capsule, which is why preoperative imaging to assess capsule integrity is increasingly valued.17PubMed. Preoperative OCT lens evaluation in posterior subcapsular cataract – prevention of complications from phacoemulsification

Another frustrating aspect of PSC is that it can cause significant visual symptoms while the rest of the lens remains largely clear. This makes the surgical decision feel less straightforward to some patients. The lens is mostly transparent, yet glare and reading difficulty are real and limiting. Surgeons familiar with PSC recognize that the standard “your cataract isn’t bad enough for surgery” metric, often based on visual acuity alone, can underestimate the functional impact of this cataract type.

After Surgery and the Risk of Secondary Cataracts

One concern specific to PSC patients is posterior capsule opacification, sometimes called a secondary cataract. After the natural lens is removed, the thin capsular bag remains to hold the artificial lens. Residual lens epithelial cells can proliferate on that bag, clouding it over months or years. This process shares the same TGF-beta-driven cell behavior that causes the original PSC. A study comparing patients whose PSC was caused by steroids with those whose PSC was not related to steroid use found that both groups undergo this complication, and both needed monitoring after surgery.18PubMed. Posterior capsule opacification in eyes with steroid-induced cataracts: Comparison of early results When posterior capsule opacification does occur, it is treated with a quick, painless laser procedure called YAG capsulotomy that clears the membrane in seconds.

In terms of quality-of-life recovery, PSC patients tend to report the greatest improvement in far-distance daily activities after surgery. A study comparing quality of life across cataract types found that at one month after surgery, the differences between nuclear, cortical, and PSC groups had essentially disappeared, with all groups reaching similar satisfaction scores.19PubMed Central. Quality of life assessment for nuclear, cortical, posterior subcapsular patients before and after cataract surgery This is encouraging for PSC patients, who often feel their preoperative symptoms are out of proportion to what their eye charts show. Surgery tends to resolve that mismatch dramatically.

Are Eye Drops an Alternative to Surgery

No eye drop currently approved by major regulatory agencies can reverse a posterior subcapsular cataract. However, research into pharmacological options is active. Early-stage studies have looked at compounds like pirenoxine and N-acetylcarnosine. Pirenoxine eye drops showed some ability to slow opacity in posterior subcapsular and cortical regions in treated eyes compared to baseline, and N-acetylcarnosine drops over six to nine months showed reduced lens opacity and improved visual function in cataract patients.20PubMed Central. Pharmacological Strategies for Cataract Management: From Molecular Targets to Clinical Translation These findings are intriguing but preliminary. The studies are small, follow-up periods are short, and no drop has been shown to eliminate the need for surgery in a patient with visually significant PSC. For now, drops may at best delay progression in early-stage cataracts. Anyone marketing an eye drop as a cure for cataracts is getting ahead of the science.

Practical coping strategies while you wait for or consider surgery include wearing polarized sunglasses to manage glare, using task lighting positioned behind you rather than overhead, increasing font size on screens, and asking your eye doctor about anti-glare coatings on your prescription glasses. These measures do not treat the cataract but can meaningfully reduce day-to-day frustration.

PSC Cataracts in Younger Adults

Because many PSC risk factors are not age-dependent, this cataract type shows up in people well below the typical cataract age range. A 10-year study of cataracts in Korean adults aged 30 to 49 found that posterior subcapsular cataracts accounted for about 35% of cases in that age group, nearly tied with anterior polar cataracts as the most common type.21PubMed Central. Cataracts among Adults Aged 30 to 49 Years: A 10-Year Study from 1995 to 2004 in Korea That is a strikingly high proportion, given that nuclear cataracts overwhelmingly dominate the older population.

For younger patients, the diagnosis can feel unexpected and alarming. You may associate cataracts with elderly grandparents, not with yourself in your thirties or forties. But if you have been on long-term steroids for asthma, an autoimmune condition, or a transplant, or if you manage diabetes, or if your work involves radiation, PSC is worth knowing about. Early detection matters because the symptoms can creep up. You might blame worsening night driving on tired eyes or assume that reading difficulty is just normal aging, when in fact a small PSC plaque is already forming. A dilated eye exam is the only reliable way to catch it early.

How PSC Differs From the Cataract Your Parents Probably Had

When most people hear “cataract,” they picture the gradual yellowing and hardening of the lens center that ophthalmologists call nuclear sclerosis. That type progresses slowly over years, causes a shift toward nearsightedness (the so-called “second sight” phenomenon where reading temporarily improves), and eventually makes everything look dim and brownish. PSC behaves differently in almost every way. It can worsen over months rather than years, it disproportionately impairs reading and near vision rather than distance vision first, and its signature symptom is glare rather than dimness. A person with a nuclear cataract might squint in low light; a person with a PSC might wince in bright light.

The distinction matters for reading and close work. PSC’s location at the back of the lens means it has an outsized effect on tasks that require a constricted pupil, like reading small print. Research on visual function across cataract types confirms that the relationship between standard acuity measurements and real-world performance varies by cataract morphology, with PSC patients often reporting worse functional difficulty than their acuity numbers would predict.22Investigative Ophthalmology & Visual Science. Impairment of Visual Acuity and Reading Performance and the Relationship with Cataract Type and Density If your eye doctor seems surprised by how much trouble you are having given your chart results, mentioning that you have a PSC, not a nuclear cataract, may prompt a closer look at functional measures like glare testing and contrast sensitivity.

Monitoring if You Are on Long-Term Steroids

If you take corticosteroids regularly, the single most practical step you can take is scheduled eye exams. Guidelines vary by specialty, but many rheumatologists and pulmonologists suggest a baseline eye exam when starting chronic steroids and then annual follow-ups. The challenge is that steroid-induced PSC does not always reverse when the medication is stopped, so catching it early gives you and your doctor the best chance of adjusting the treatment plan before vision loss becomes significant.

Not all steroid formulations carry the same risk. Oral prednisone at moderate to high doses for months is the classic culprit, but inhaled corticosteroids for asthma and COPD carry a lower but real risk, especially at high doses over years. Steroid eye drops used after eye surgery or for inflammatory conditions deliver drug directly to the lens and can accelerate PSC formation quickly. If you are using steroid drops for more than a few weeks, your prescribing doctor should be monitoring your lens and eye pressure at regular intervals.

The question patients often ask is whether switching to a non-steroidal anti-inflammatory alternative can prevent further progression. Sometimes it can, if the PSC is caught early and the underlying condition can be managed another way. For many patients, though, the steroid is controlling a serious disease, and the calculus becomes one of managing competing risks. The answer is almost never to stop a needed medication unilaterally; it is to have the conversation with both your prescriber and your eye doctor so the lens can be watched and surgery planned electively if the cataract advances.